Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues.
Chen W, Zhou J, Wu K, Huang J, Ding Y, Yun EJ, Wang B, Ding C, Hernandez E, Santoyo J, Chen H, Lin H, Sagalowsky A, He D, Zhou J, Hsieh JT.
Chen W, et al. Among authors: wang b.
Oncotarget. 2016 Aug 30;7(35):56842-56854. doi: 10.18632/oncotarget.10863.
Oncotarget. 2016.
PMID: 27472396
Free PMC article.